Anti-CCL22 increases regulatory T�cells in CD4+ T�cells of rheumatoid arthritis patients via STAT5 pathway-Reference-Cited by-同舟云学术

Anti-CCL22 increases regulatory T�cells in CD4+ T�cells of rheumatoid arthritis patients via STAT5 pathway

Published:2019-12-31 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Wang Ling¹,Wang Ling²,Hao Ping³,Cao Qiwei⁴,Zhang Zhenxian⁵

Affiliation:

1. Department of EM, Shuguang Hospital Affiliated to Shanghai University of TCM, Shanghai 200021, P.R. China

2. Department of Nephrology, Renji Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200001, P.R. China

3. Department of Orthopedics, Ruijing Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200025, P.R. China

4. Department of Rheumatism and Immunology, Shanghai Fourth People's Hospital, Shanghai 200081, P.R. China

5. Traditional Chinese Medicine and Preventive Treatment Center, Yueyang Hospital Affiliated to Shanghai University of TCM, Shanghai 200437, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel-group study;Modern Rheumatology;2024-01-13

2. A review on pharmacokinetics of sinomenine and its anti-inflammatory and immunomodulatory effects;International Immunopharmacology;2023-06

3. Complexity and diversity of FOXP3 isoforms: Novel insights into the regulation of the immune response in metastatic breast cancer;International Immunopharmacology;2023-05

4. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis;Frontiers in Immunology;2023-02-13

5. Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation;Journal of Allergy and Clinical Immunology;2023-01